The Centers for Medicare & Medicaid Services released a proposed rule July 1 to trim 12% off the composite rate in the end-stage renal disease bundle to make up for significant drops in the use of anemia drugs, and included some new measures for the ESRD Quality Incentive Program for calendar year 2014.
The cut would actually amount to 9.4%, because the agency would give the renal community a 2.6% increase based on the market basket analysis for 2014. If finalized later this year, the proposed changes to the Prospective Payment System for the ESRD Program would reduce the Medicare composite base rate from $240.36 per dialysis patient per treatment to $216.95 per treatment.
Below are the formal responses submitted to CMS by the renal community. Do you have a response you would like to include here? Send it to Rebecca Zumoff at email@example.com